Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohiro Nobushita

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Hinyokika Kiyo. Acta Urologica Japonica|August 17, 2012
[Staghorn silicate calculi: a case report]Tomotaka Toba, Hiroshi Koike, Tomohiro Nobushita
International Journal of Urology : Official Journal of the Japanese Urological Association|February 14, 2008
Renal cell carcinomas arising from the allograft and bilateral native kidneysTomohiro Nobushita, Noboru Hara, Yuki Nakagawa, et al.
Urologia Internationalis|August 31, 2013
The RENAL nephrometry score and the PADUA classification for the prediction of perioperative outcomes in patients receiving nephron-sparing surgery: feasible tools to predict intraoperative conversion to nephrectomyKazuhiro Kobayashi, Toshihiro Saito, Yasuo Kitamura, et al.
Diagnostic Pathology|April 10, 2013
Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomyKazuhiro Kobayashi, Toshihiro Saito, Yasuo Kitamura, et al.
Urologic Oncology|August 6, 2013
Effect of the time from the presentation of symptoms to medical consultation on primary tumor size and survival in patients with testicular cancer: Shift in the last 2 decadesKazuhiro Kobayashi, Toshihiro Saito, Yasuo Kitamura, et al.
Urologic Oncology|December 27, 2008
Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURPNoboru Hara, Hiroshi Koike, Tomohiro Nobushita, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 23, 2019
[THE USE OF BORTEZOMIB FOR THE TREATMENT OF CHRONIC ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION]Masayuki Tasaki, Kazuhide Saito, Yuki Nakagawa, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Hinyokika Kiyo. Acta Urologica Japonica|August 17, 2012
[Staghorn silicate calculi: a case report]Tomotaka Toba, Hiroshi Koike, Tomohiro Nobushita
International Journal of Urology : Official Journal of the Japanese Urological Association|February 14, 2008
Renal cell carcinomas arising from the allograft and bilateral native kidneysTomohiro Nobushita, Noboru Hara, Yuki Nakagawa, et al.
Urologia Internationalis|August 31, 2013
The RENAL nephrometry score and the PADUA classification for the prediction of perioperative outcomes in patients receiving nephron-sparing surgery: feasible tools to predict intraoperative conversion to nephrectomyKazuhiro Kobayashi, Toshihiro Saito, Yasuo Kitamura, et al.
Diagnostic Pathology|April 10, 2013
Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomyKazuhiro Kobayashi, Toshihiro Saito, Yasuo Kitamura, et al.
Urologic Oncology|August 6, 2013
Effect of the time from the presentation of symptoms to medical consultation on primary tumor size and survival in patients with testicular cancer: Shift in the last 2 decadesKazuhiro Kobayashi, Toshihiro Saito, Yasuo Kitamura, et al.
Urologic Oncology|December 27, 2008
Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURPNoboru Hara, Hiroshi Koike, Tomohiro Nobushita, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 23, 2019
[THE USE OF BORTEZOMIB FOR THE TREATMENT OF CHRONIC ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION]Masayuki Tasaki, Kazuhide Saito, Yuki Nakagawa, et al.
Pageof 1